Moreover, expression of GPR84 was not detectable on hepatic stellate cells (HSC), the key matrix-producing cell type responsible of liver fibrosis progression [9,31], supporting that the antifibrotic effects of GPR84 antagonists were related to their inhibition of myeloid cells (and not HSC directly). This evidence concerns the gene GPR84 and Hepatic fibrosis.